SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-012168
Filing Date
2022-05-05
Accepted
2022-05-05 08:05:31
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51566
2 ex99-1.htm EX-99.1 228563
3 ex99-1_001.jpg GRAPHIC 3247
  Complete submission text file 0001493152-22-012168.txt   477301

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xtnt-20220505.xsd EX-101.SCH 3045
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xtnt-20220505_lab.xml EX-101.LAB 35156
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xtnt-20220505_pre.xml EX-101.PRE 23037
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3667
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 22894169
SIC: 2836 Biological Products, (No Diagnostic Substances)